Testing effectiveness (Phase 2)Study completedNCT00940225What this trial is testingStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesWho this might be right forSolid TumorsCancer Exelixis 730
Early research (Phase 1)Ended earlyNCT02714374What this trial is testingGL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ CancersWho this might be right forSolid Organ Cancers Andrew Lowy 5
Early research (Phase 1)Study completedNCT01522820What this trial is testingVaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid TumorsWho this might be right forAnaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT04208958What this trial is testingStudy of VE800 and Nivolumab in Patients With Selected Types of Advanced or Metastatic CancerWho this might be right forMetastatic CancerMelanomaGastric Cancer+2 more Vedanta Biosciences, Inc. 56
Large-scale testing (Phase 3)Not Yet RecruitingNCT07362186What this trial is testingLM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction AdenocarcinomaWho this might be right forLocally Advanced or Metastatic GC and GCJ Adenocarcinoma LaNova Medicines Limited 400
Testing effectiveness (Phase 2)Study completedNCT01896531What this trial is testingIpatasertib (GDC-0068) in Combination With Fluoropyrimidine Plus Oxaliplatin in Participants With Advanced or Metastatic Gastric or Gastroesophageal Junction CancerWho this might be right forGastric Cancer Genentech, Inc. 153
Early research (Phase 1)UnknownNCT05315830What this trial is testingHER2 Tumor Vaccine in Patients With Her-2 Positive Gastric/GEJ Adenocarcinoma EsophagogastricWho this might be right forAdenocarcinoma - GEJAdenocarcinoma of the Stomach The First Affiliated Hospital of Bengbu Medical University 10
Early research (Phase 1)Study completedNCT03821233What this trial is testingA Dose Finding Study of ZW49 in Patients With HER2-Positive CancersWho this might be right forHER2-expressing Cancers Zymeworks BC Inc. 112
Testing effectiveness (Phase 2)Ended earlyNCT00683787What this trial is testingDocetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction CancerWho this might be right forGastric Cancer Roswell Park Cancer Institute 8
Not applicableUnknownNCT04915807What this trial is testingReal-world Data (RWD) of Ramucirumab Plus PaclitaxelWho this might be right forGastric CancerGastroesophageal Junction Adenocarcinoma Hallym University Medical Center 222
Testing effectiveness (Phase 2)UnknownNCT03544723What this trial is testingSafety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.Who this might be right forSolid TumorLymphoma MultiVir, Inc. 40
Testing effectiveness (Phase 2)UnknownNCT04202484What this trial is testingTripletrumab Combined With Oxaliplatin and Teggio (SOX) in First-line Treatment of Gastric and Gastroesophageal Junction AdenocarcinomaWho this might be right forGastric Cancer RenJi Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT06330064What this trial is testingEvaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)Who this might be right forRecurrent or Metastatic Solid Tumors Daiichi Sankyo 520
Testing effectiveness (Phase 2)Study completedNCT01262482What this trial is testingStudy of Oxaliplatin and Sorafenib Combination to Treat Gastric Cancer Relapsed After a Cisplatin Based TreatmentWho this might be right forAdvanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (Relapsed After a Cisplatin Based Treatment) Grupo Espanol Multidisciplinario del Cancer Digestivo 41
Early research (Phase 1)Study completedNCT00004065What this trial is testingChemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic CancerWho this might be right forBladder CancerBreast CancerColorectal Cancer+9 more Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT02572687What this trial is testingRamucirumab (LY3009806) Plus MEDI4736 in Participants With Advanced Gastrointestinal or Thoracic MalignanciesWho this might be right forGastric CancerGastroesophageal Junction AdenocarcinomaNon-Small Cell Lung Cancer+1 more Eli Lilly and Company 85
Testing effectiveness (Phase 2)Looking for participantsNCT05640609What this trial is testingCapeox Regimen Combined With Sintilimab and Bevacizumab for Gastric CancerWho this might be right forStomach Neoplasm West China Hospital 57
Early research (Phase 1)Ended earlyNCT01705340What this trial is testingAkt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By SurgeryWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionHER2-positive Breast CancerMale Breast Cancer+9 more National Cancer Institute (NCI) 60
Early research (Phase 1)Looking for participantsNCT06427941What this trial is testingBGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid TumorsWho this might be right forMetastatic Hepatocellular CarcinomaLocal Advanced Hepatocellular CarcinomaAlpha-fetoprotein (AFP)-Producing Gastric Cancer+2 more BeOne Medicines 140
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24